Publications & Posters
Scholarly publications
Spinal Muscular Atrophy
Apitegromab
October 2024
World Muscle Society Annual Congress
Longer-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with nonambulatory SMA: Results from the 48-month TOPAZ study
Spinal Muscular Atrophy
Apitegromab
October 2024
World Muscle Society Annual Congress
Apitegromab in spinal muscular atrophy: Baseline characteristics of participants enrolled in the phase 3 SAPPHIRE study
Spinal Muscular Atrophy
Apitegromab
July 2024
Frontiers in Neurology
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study
Platform
July 2024
FASEB Science Research Conferences: TGFβ Superfamily
Structural characterization of selective inhibitors of TGFβ1 activation with differing mechanisms of action and clinical potential
Platform
July 2024
FASEB Science Research Conferences: TGFβ Superfamily
Structural characterization of selective inhibitors of TGFβ1 activation with differing mechanisms of action and clinical potential
Fibrosis
SRK-373
July 2024
Science Signaling
